233 related articles for article (PubMed ID: 9066699)
1. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
Wesolowska O; Molnár J; Motohashi N; Michalak K
Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
[TBL] [Abstract][Full Text] [Related]
5. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
8. Antiplasmid activity: loss of bacterial resistance to antibiotics.
Molnár J; Földeák S; Nakamura MJ; Rausch H; Domonkos K; Szabó M
APMIS Suppl; 1992; 30():24-31. PubMed ID: 1295542
[TBL] [Abstract][Full Text] [Related]
9. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
Ford JM; Prozialeck WC; Hait WN
Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
[TBL] [Abstract][Full Text] [Related]
10. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.
Hendrich AB; Wesołowska O; Poła A; Motohashi N; Molnár J; Michalak K
Mol Membr Biol; 2003; 20(1):53-60. PubMed ID: 12745926
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines.
Motohashi N; Kurihara T; Kawase M; Hevér A; Tanaka M; Szabo D; Nacsa J; Yamanaka W; Kerim A; Molnár J
Anticancer Res; 1997; 17(5A):3537-43. PubMed ID: 9413199
[TBL] [Abstract][Full Text] [Related]
12. 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.
Shah A; Naliapara Y; Sureja D; Motohashi N; Kawase M; Miskolci C; Szabo D; Molnár J
Anticancer Res; 1998; 18(4C):3001-4. PubMed ID: 9713499
[TBL] [Abstract][Full Text] [Related]
13. Tomato lectin labels the 180 kD glycoform of P-glycoprotein in rat brain capillary endothelia and mdr tumor cells.
Fakla I; Hever A; Molnár J; Fischer J
Anticancer Res; 1998; 18(4C):3107-11. PubMed ID: 9713518
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cancer multidrug resistance by green tea polyphenols.
Mei Y; Qian F; Wei D; Liu J
J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
[TBL] [Abstract][Full Text] [Related]
15. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
17. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the MDR1 transporter by new phenothiazine derivatives.
Kónya A; Andor A; Sátorhelyi P; Németh K; Kurucz I
Biochem Biophys Res Commun; 2006 Jul; 346(1):45-50. PubMed ID: 16750172
[TBL] [Abstract][Full Text] [Related]
19. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]